Found 13 results
[ Author(Desc)] Title Type Year
Filters: Author is Hong M Moulton  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
M
H. Moulton and JD, M., Morpholino Oligomers: Methods and Protocols. Methods in Molecular Biology. Humana Press, 2017.
H. Moulton, Hase, M. C., Smith, K. M., and Iversen, P. L., HIV Tat peptide enhances cellular delivery of antisense morpholino oligomers., Antisense & nucleic acid drug development, vol. 13, no. 1, pp. 31-43, 2003.
H. Moulton and Moulton, J. D., Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy., Biochimica et biophysica acta, vol. 1798, no. 12, pp. 2296-303, 2010.
H. Moulton and Moulton, J. D., Morpholinos and their peptide conjugates: therapeutic promise and challenge for Duchenne muscular dystrophy., Biochim Biophys Acta, vol. 1798, no. 12, pp. 2296-303, 2010.
H. Moulton, Nelson, M. H., Hatlevig, S. A., Reddy, M. T., and Iversen, P. L., Cellular uptake of antisense morpholino oligomers conjugated to arginine-rich peptides., Bioconjugate chemistry, vol. 15, no. 2, pp. 290-9, 2004.
H. Moulton, Cell-penetrating peptides enhance systemic delivery of antisense morpholino oligomers., Methods in molecular biology (Clifton, N.J.), vol. 867, pp. 407-14, 2012.
H. Moulton, In vivo delivery of morpholino oligos by cell-penetrating peptides., Curr Pharm Des, vol. 19, no. 16, pp. 2963-9, 2013.
H. Moulton and Moulton, J. D., Arginine-rich cell-penetrating peptides with uncharged antisense oligomers., Drug discovery today, vol. 9, no. 20, p. 870, 2004.
H. Moulton, In vivo delivery of morpholino oligos by cell-penetrating peptides., Current pharmaceutical design, vol. 19, no. 16, pp. 2963-9, 2013.
H. Moulton, Yoshihara, P. H., Mason, D. H., Iversen, P. L., and Triozzi, P. L., Active specific immunotherapy with a beta-human chorionic gonadotropin peptide vaccine in patients with metastatic colorectal cancer: antibody response is associated with improved survival., Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 8, no. 7, pp. 2044-51, 2002.
H. Moulton, Fletcher, S., Neuman, B. W., McClorey, G., Stein, D. A., Abes, S., Wilton, S. D., Buchmeier, M. J., Lebleu, B., and Iversen, P. L., Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo., Biochemical Society transactions, vol. 35, no. Pt 4, pp. 826-8, 2007.
H. Moulton and Moulton, J. D., Peptide-assisted delivery of steric-blocking antisense oligomers., Current opinion in molecular therapeutics, vol. 5, no. 2, pp. 123-32, 2003.
H. Moulton, Wu, B., Jearawiriyapaisarn, N., Sazani, P., Lu, Q. Long, and Kole, R., Peptide-morpholino conjugate: a promising therapeutic for Duchenne muscular dystrophy., Annals of the New York Academy of Sciences, vol. 1175, pp. 55-60, 2009.